Dexamethasone enhances risk of herpes zoster in severe COVID-19 infection

Infection. 2022 Aug;50(4):1029-1030. doi: 10.1007/s15010-021-01747-x. Epub 2021 Dec 22.

Authors

Nathan B Price¹, Charles Grose²

Affiliations

¹ Division of Infectious Diseases, Department of Pediatrics, University of Arizona, Tucson, AZ, USA.
² Division of Infectious Diseases/Virology Laboratory, Department of Pediatrics, University of Iowa Hospital, Room BT2001, 200 Hawkins Drive, Iowa City, IA, 52242, USA. Charles-grose@uiowa.edu.

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19 Drug Treatment*
Dexamethasone / therapeutic use
Herpes Zoster* / complications
Herpes Zoster* / drug therapy
Humans

Substances

Dexamethasone

Grants and funding

R21 AI153817/AI/NIAID NIH HHS/United States